Loading...
LGND logo

Ligand Pharmaceuticals Community

NasdaqGM:LGND Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

Community Investing Ideas

LGND logo
Ligand Pharmaceuticals

Expanding Royalty Portfolio Will Strengthen Global Healthcare Reach

Key Takeaways Diverse royalty partnerships, new therapeutic categories, and global healthcare trends boost recurring revenue, earnings visibility, and long-term margin potential. Opportunistic asset-light acquisitions and strong industry positioning underpin margin expansion, pipeline growth, and sustained revenue momentum.

View narrative
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
US$183.13
2.1% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
18.93% p.a.
Profit Margin
39.75%
Future PE
37.33x
Share price in 2028
US$214.16